Q3 2020 Holdings
Filed 2020-11-16 | 16 holdings | $19.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $19.3M | 658,908 | 98.2% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $122.4K | 5,344,971 | 0.6% |
| Morphic Holding | Common Stock | 61775R105 | $81.4K | 2,977,832 | 0.4% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $41.2K | 3,320,608 | 0.2% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $33.2K | 1,788,160 | 0.2% |
| Checkmate Pharmaceuticals | Common Stock | 162818108 | $15.4K | 1,335,050 | 0.1% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $14.1K | 2,600,410 | 0.1% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $11.3K | 1,284,900 | 0.1% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $6.1K | 912,693 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $5.7K | 2,005,249 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $5.5K | 1,375,907 | 0.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $5.4K | 130,646 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.7K | 334,965 | 0.0% |
| ObsEva | Common Stock | H5861P103 | $2.5K | 999,364 | 0.0% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $1.9K | 187,538 | 0.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $1.6K | 750,741 | 0.0% |